Which of the following is a benefit of using montelukast?

Montelukast is a leukotriene receptor antagonist that is primarily used to manage asthma and allergic rhinitis. One of its key benefits is its ability to prevent exercise-induced bronchoconstriction, making it particularly valuable for individuals who experience asthma symptoms triggered by physical activity. By inhibiting the action of leukotrienes, which are inflammatory mediators that contribute to airway constriction and hyper-responsiveness, montelukast helps to maintain open airways during exercise, reducing the likelihood of asthmatic symptoms such as wheezing and shortness of breath.

While it is an effective component of asthma management and can improve overall lung function and quality of life, it does not cure asthma, eliminate the need for inhalers, or reduce lung infections. Therefore, the ability to prevent exercise-induced bronchoconstriction is a significant therapeutic advantage of montelukast that distinguishes it within asthma treatment options.